Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
cis-UCA in dry eye syndrome
NCT02326090Phase 2Completed
- Sponsor
- Herantis Pharma
- Start
- Dec 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cis-Urocanic acid in dry eye syndrome (DED), sponsored by Herantis Pharma. Started Dec 2014; status: completed.
02
Drugs
cis-Urocanic acid
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02326090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02326090.